Skip to content
  • About
    • Company Overview
    • Company History
    • Board of Directors
    • Management Team
    • Organization Chart
    • ESG
  • Pipeline
    • Globo H
      • Adagloxad simolenin (Vaccine)
      • OBI-833 (Vaccine)
      • OBI-999 (ADC)
    • SSEA-4
      • OBI-866 (Vaccine)
    • AKR1C3
      • OBI-3424 (Prodrug)
  • News
    • News
    • Company Presentation
    • Reference Library
  • Investors
    • Investor Overview
    • About
      • Company Profile
      • Corporate Governance
      • Stakeholder
    • News&Events
      • Announcements
      • Event Calendar
    • Financial Information
      • Annual Report
      • Financial Report​
      • Monthly Revenues
      • Stock Quote
  • Careers
  • Contact
  • 繁體中文
  • About
    • Company Overview
    • Company History
    • Board of Directors
    • Management Team
    • Organization Chart
    • ESG
  • Pipeline
    • Globo H
      • Adagloxad simolenin (Vaccine)
      • OBI-833 (Vaccine)
      • OBI-999 (ADC)
    • SSEA-4
      • OBI-866 (Vaccine)
    • AKR1C3
      • OBI-3424 (Prodrug)
  • News
    • News
    • Company Presentation
    • Reference Library
  • Investors
    • Investor Overview
    • About
      • Company Profile
      • Corporate Governance
      • Stakeholder
    • News&Events
      • Announcements
      • Event Calendar
    • Financial Information
      • Annual Report
      • Financial Report​
      • Monthly Revenues
      • Stock Quote
  • Careers
  • Contact
  • 繁體中文

Financial Report

2022

2022Q1 Consolidated
2022Q2 Consolidated
2022Q3 Consolidated

2021

2021Q1 Consolidated
2021Q2 Consolidated
2021Q3 Consolidated
2021 Consolidated
2021 Parent Company

2020

2020Q1 Consolidated
2020Q2 Consolidated
2020Q3 Consolidated
2020 Consolidated
2020 Parent Company

2019

2019Q1 Consolidated
2019Q2 Consolidated
2019Q3 Consolidated
2019 Consolidated
2019 Parent Company

2018

2018Q1 Consolidated
2018Q2 Consolidated
2018Q3 Consolidated
2018 Consolidated

2017

2017Q1 Consolidated
2017Q2 Consolidated
2017Q3 Consolidated
2017 Consolidated

2016

2016Q1 Consolidate
2016Q2 Consolidated
2016Q3 Consolidated
2016 Consolidated

2015
2015 Consolidated
2014
2014 Consolidated
2013
2013 Consolidated
2012
2012Consolidated

Company Overview

Management Team

ESG

Pipeline

News

Investor Overview

Careers

Contact

Date Privacy Notice

© 2020 OBI Pharma.Web Development by 展躍設計

We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies.
Cookie SettingsAccept
Manage consent
必要性
Always Enabled
必要性cookies在網站內是絕對重要的功能, 此分類僅包含功能性及安全性的cookies, 此cookies不會存取任何個人隱私資料。
非必要性
任何對於網站潛在必要性的cookies已經使用, 非必要性則為收集個資, 數據, 廣告置入等..
SAVE & ACCEPT
  •  

  •